+ Watch PPHM
on My Watchlist
A biopharmaceutical company with a portfolio of clinical stage and pre-clinical product candidates using monoclonal antibodies for the treatment of cancer and viral diseases.
Looks like I got out from under that last badly-timed red thumb on Peregrine a little quicker than I thought. Am I setting myself up for another one? Part of me wants Peregrine to keep the lights on a few more years so that I can keep riding the waves back into score leadership, which was cruelly stolen from me. Another part of me just wants the company to die so I can stop giving myself migraines trying to follow their soap opera drug trials. I only have a limited amount of time and I need to spend most of it on trade grade stocks, not floating dust particles like Peregrine. Damn you, OCD.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions